Sitagliptin Phosphate Monohydrate
磷酸西格列汀一水合物
Report date: 2023/12/26 13:48:23
NMEFirst In Class
Base Information
Drug NameSitagliptin Phosphate Monohydrate
Drug Alias Name +[20]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[29]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2006/10/16
Country/Territory +[12]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A
Develop Information
Active CompaniesMerck Sharp & Dohme BvMerck & Co IncMerck Sharp & Dohme Ltd +[4]
Inactive CompaniesInstitut National De La Santé Et De La Recherche Médicale, France U979Ludwig Maximilians University Of MunichUniversity Of Copenhagen +[26]
Active Indications
Inactive Indications +[28]